1. Academic Validation
  2. Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties

Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties

  • Bioorg Med Chem. 2016 Nov 1;24(21):5618-5625. doi: 10.1016/j.bmc.2016.09.028.
Ayna Alfadhli 1 Andrew Mack 1 Logan Harper 1 Sam Berk 1 Christopher Ritchie 1 Eric Barklis 2
Affiliations

Affiliations

  • 1 Oregon Health & Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States.
  • 2 Oregon Health & Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States. Electronic address: barklis@ohsu.edu.
Abstract

We have analyzed a set of quinolinequinones with respect to their reactivities, cytotoxicities, and anti-HIV-1 properties. Most of the quinolinequinones were reactive with glutathione, and several acted as sulfhydryl crosslinking agents. Quinolinequinones inhibited binding of the HIV-1 matrix protein to RNA to varying degrees, and several quinolinequinones showed the capacity to crosslink HIV-1 matrix proteins in vitro, and HIV-1 structural proteins in virus particles. Cytotoxicity assays yielded quinolinequinone CC50 values in the low micromolar range, reducing the potential therapeutic value of these compounds. However, one compound, 6,7-dichloro-5,8-quinolinequinone potently inactivated HIV-1, suggesting that quinolinequinones may prove useful in the preparation of inactivated virus vaccines or for Other virucidal purposes.

Keywords

HIV; Quinolinequinone; Virus.

Figures